PMO-085 Safety and subsequent use of prophylactic percutaneous gastrostomy placement by endoscopically assisted gastropexy and direct puncture using the fresenius^®pexact kit in head and neck cancer patients

Abstract

addition, the time from referral to insertion increased significantly across these periods (p<0.01). In the later part of 2011 an increase in referrals and appropriate insertions was observeddwithout a concomitant rise in complications. Conclusion Introduction of a "virtual" team for PEG assessment reduced the number of procedures required (freeing time for other endoscopic procedures), and post-insertion complications. There was a non-significant trend for improved 30-day mortality. A "minimal input" approach to PEG assessment based on a detailed referral form is therefore feasible, safe and associated with significantly reduced rates of post-procedure morbidity.

Tumor implantation following percutaneous endoscopic gastrostomy insertion for head and neck and oesophageal cancer: Review of the literature

“…In the eight retrospective series based around an index case of seeding, seeding was observed in 15 of 1742 patients with head and neck cancer (0.86%). In contrast, only two cases were identified in the randomized trial and the remaining prospective and retrospective series (2/3049; 0.07%). Combining both sets of data, the overall incidence of seeding in patients with head and neck cancer was 0.35% (17/4791) and 0.25% (1/397) in those with oesophageal cancer.…”

“…Data from the randomized trial, the 27 retrospective and 2 prospective case series are summarized in Table .…”